Degarelix
Degarelix is a synthetic peptide antagonist of the gonadotropin-releasing hormone (GnRH) receptor. It is utilized in prostate cancer research to rapidly suppress testosterone production, facilitating studies on androgen deprivation in both in vitro cellular models and in vivo xenograft experiments.
Product Specifications
Product Name Alternative
GNRH Receptor, GnRHR, GNRHReceptor, FE200486 free base, FE 200486 free base, Degarelix
Field of Research
Cell Biology, Pharmacology & Drug Discovery
Purity
99.34% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (0.61 mM) ; H2O:4 mg/mL (2.45 mM) ; DMSO:8 mg/mL (4.9 mM)
Molecular Weight
1632.26
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog